Hillsdale Investment Management’s NCI, Inc. NCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-28,690
Closed -$605K 558
2017
Q2
$605K Buy
+28,690
New +$492K 0.12% 170
2016
Q3
Sell
-34,140
Closed -$480K 593
2016
Q2
$480K Buy
34,140
+5,000
+17% +$68.9K 0.14% 100
2016
Q1
$408K Sell
29,140
-60
-0.2% -$814 0.14% 148
2015
Q4
$399K Buy
29,200
+7,700
+36% +$115K 0.15% 139
2015
Q3
$285K Sell
21,500
-2,400
-10% -$30.2K 0.1% 224
2015
Q2
$247K Sell
23,900
-1,900
-7% -$19.9K 0.07% 318
2015
Q1
$267K Buy
25,800
+5,000
+24% +$56.5K 0.07% 315
2014
Q4
$212K Hold
20,800
0.05% 322
2014
Q3
$198K Hold
20,800
0.06% 308
2014
Q2
$185K Hold
20,800
0.04% 330
2014
Q1
$221K Buy
+20,800
New +$193K 0.06% 294

Hillsdale Investment Management's NCIT Position: Q3 2017 in Review

Hillsdale Investment Management sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 28,690 shares — an estimated $605K sold.

Hillsdale Investment Management first reported a position in NCIT in Q1 2014 and held it in 11 quarters. The position peaked at $605K in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Hillsdale Investment Management reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Hillsdale Investment Management sold 28,690 NCI, Inc. shares in Q3 2017, an estimated $605K.
  • Hillsdale Investment Management first reported a position in NCI, Inc. in Q1 2014 and held it in 11 quarters.
  • Hillsdale Investment Management's NCI, Inc. position peaked at $605K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Hillsdale Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.